OpeyemiAOlabisiMDPhD
Nephrology • Durham, NCChronic Renal Failure & Dialysis, Glomerular Disease, Hereditary Kidney Disease Genetics
Nephrologist, Duke University Hospital
Dr. Olabisi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
DUMC 104775
300 N. Duke St.,
Durham, NC 27701Phone+1 919-660-6987Fax+1 919-684-0901
Summary
- Dr. Opeyemi Olabisi is a nephrologist in Durham, NC and is affiliated with Duke University Hispital. He received his medical degree from Albert Einstein College of Medicine and has been in practice 8 years. He specializes in chronic renal failure & dialysis, glomerular disease, and hereditary kidney disease genetics and is experienced in biomedical research.
Education & Training
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2012 - 2015
Massachusetts General HospitalResidency, Internal Medicine, 2009 - 2012
Albert Einstein College of MedicineClass of 2009
Certifications & Licensure
NC State Medical License 2019 - 2025
MA State Medical License 2012 - 2021- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Harold Amos Medical Faculty Development Award Robert Wood Johnson
Clinical Trials
- Duke APOL1 Research Biorepository Start of enrollment: 2019 Dec 13
Publications & Presentations
PubMed
- 82 citationsRegulation of Transcription Factor NFAT by ADP-RibosylationOpeyemi A. Olabisi, Noemi Soto-Nieves, Edward Nieves, Teddy T.C. Yang, Xiao Yong Yang
Molecular and Cellular Biology. 2008-05-01 - 154 citationsAPOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinasesOpeyemi A. Olabisi, Jia-Yue Zhang, Lynn VerPlank, Nathan Zahler, Salvatore DiBartolo
Proceedings of the National Academy of Sciences of the United States of America. 2016-01-26 - 23 citationsJAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids.Sarah E Nystrom, Guojie Li, Somenath Datta, Karen L Soldano, Daniel Silas
JCI Insight. 2022-06-08
Books/Book Chapters
Press Mentions
Targeting the Uneven Burden of Kidney Disease on Black AmericansMay 17th, 2022
Advancing Diversity and Inclusion Through Faculty Development AwardsFebruary 10th, 2016
Grant Support
- Harold Amos Medical Faculty Development GrantRWJF2016–2020
- MARC Predoctoral FellowshipNational Institute Of General Medical Sciences2004–2006
- MARC Predoctoral FellowshipNational Institute Of General Medical Sciences2002–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
